4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-025252
Director sold 74,000 shares at $15.09 ($1,116,660)
- Director acquired 71,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ABERCROMBIE GEORGE B · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-10 | Exercise or conversion : show line 1 in the form | +11,000 | $1.71 | $18,810 | 14,000 | D |
| 2021-09-10 | Exercise or conversion : show line 2 in the form | +30,000 | $3.22 | $96,600 | 44,000 | D |
| 2021-09-10 | Exercise or conversion : show line 3 in the form | +30,000 | $2.91 | $87,300 | 74,000 | D |
| 2021-09-10 | Sale : show line 4 in the form | −74,000 | $15.09 | $1,116,660 | 0 | D |
| Open-market sales · 74,000 sh · avg $15.09 · $1,116,660 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-10 | Exercise or conversion : show line 5 in the form Automatic Stock Option Grant | −11,000 | 0 | D |
| 2021-09-10 | Exercise or conversion : show line 6 in the form Automatic Stock Option Grant | −30,000 | 0 | D |
| 2021-09-10 | Exercise or conversion : show line 7 in the form Automatic Stock Option Grant | −30,000 | 0 | D |
Loading xslF345X03/form4.xml…